相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: Preliminary evidence in adolescents with treatment-resistant depression
Abhrajeet Roy et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Benefits of animal models to understand the pathophysiology of depressive disorders
Boldizsar Czeh et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
Clinical characteristics of treatment-resistant depression in adults in Hungary: Real-world evidence from a 7-year-long retrospective data analysis
Peter Doeme et al.
PLOS ONE (2021)
Augmentation with Atypical Antipsychotics for Treatment-Resistant Depression
Filippo Cantu et al.
JOURNAL OF AFFECTIVE DISORDERS (2021)
Augmentation therapy with minocycline in treatment-resistant depression patients with low-grade peripheral inflammation: results from a double-blind randomised clinical trial
Maria Antonietta Nettis et al.
NEUROPSYCHOPHARMACOLOGY (2021)
Impact of Supplementation and Nutritional Interventions on Pathogenic Processes of Mood Disorders: A Review of the Evidence
Cara T. Hoepner et al.
NUTRIENTS (2021)
Creation of a gene expression portrait of depression and its application for identifying potential treatments
Stephen C. Gammie
SCIENTIFIC REPORTS (2021)
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
Ioline D. Henter et al.
CNS DRUGS (2021)
Real-world evidence from a European cohort study of patients with treatment resistant depression: Treatment patterns and clinical outcomes
K. Heerlein et al.
JOURNAL OF AFFECTIVE DISORDERS (2021)
Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis
Sheng-Min Wang et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Nuclear hormone receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Transporters
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Sustained effects of rapidly acting antidepressants require BDNF-dependent MeCP2 phosphorylation
Ji-Woon Kim et al.
NATURE NEUROSCIENCE (2021)
MeCP2 for sustained antidepressant effects
Shane Johnson et al.
NATURE NEUROSCIENCE (2021)
Epigenetics: A missing link between early life stress and depression
Mario F. Juruena et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2021)
Fine-tuning neural excitation/inhibition for tailored ketamine use in treatment-resistant depression
Erik D. Fagerholm et al.
TRANSLATIONAL PSYCHIATRY (2021)
Risk Factors for Suicide and Suicide Attempts Among Patients With Treatment-Resistant Depression: Nested Case-Control Study
Johan Reutfors et al.
ARCHIVES OF SUICIDE RESEARCH (2021)
Prophylactic efficacy of 5-HT4R agonists against stress
Briana K. Chen et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Psychedelics and Psychedelic-Assisted Psychotherapy
Collin M. Reiff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2020)
Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders
Moriah L. Jacobson et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60 (2020)
Therapeutic Strategies for Treatment-resistant Depression: State of the Art and Future Perspectives
Kah K. Goh et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Pharmacological evidence for the involvement of the opioid system in the antidepressant-like effect of simvastatin in mice: Without tolerance and withdrawal syndrome
Mojtaba Dolatshahi et al.
NEUROSCIENCE LETTERS (2020)
Rapastinel, a novel glutamatergic agent with ketamine-like antidepressant actions: Convergent mechanisms
Taro Kato et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2020)
Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)
Muhammad Ishrat Husain et al.
BMC PSYCHIATRY (2020)
The identification, assessment and management of difficult-to-treat depression: An international consensus statement
R. H. McAllister-Williams et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Gut microbiota and major depressive disorder: A systematic review and meta-analysis
Kenji Sanada et al.
JOURNAL OF AFFECTIVE DISORDERS (2020)
Ayahuasca - potential therapeutic properties in psychiatry. Research review
Aleksandra Barabasz-Gembczyk et al.
PSYCHIATRIA POLSKA (2020)
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia
Andrew D. Krystal et al.
NATURE MEDICINE (2020)
The impact of tocilizumab on anxiety and depression in patients with rheumatoid arthritis
Shmuel Tiosano et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2020)
Pharmacological Treatments for Patients with Treatment-Resistant Depression
Valerie L. Ruberto et al.
PHARMACEUTICALS (2020)
Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)
Diego A. Pizzagalli et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Systemic neuro-dysregulation in depression: Evidence from genome-wide association
Justin D. Tubbs et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Genome-wide association studies of antidepressant class response and treatment-resistant depression
Qingqin S. Li et al.
TRANSLATIONAL PSYCHIATRY (2020)
Alzheimer's disease: Recent treatment strategies
Miguel Vaz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Could ketamine be the answer to treating treatment-resistant major depressive disorder?
Abdullah Mohammed Ramadan et al.
GENERAL PSYCHIATRY (2020)
Novel Targets to Treat Depression: Opioid-Based Therapeutics
Caroline A. Browne et al.
HARVARD REVIEW OF PSYCHIATRY (2020)
PET technology for drug development in psychiatry
Ryosuke Arakawa et al.
NEUROPSYCHOPHARMACOLOGY REPORTS (2020)
Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Management of Treatment-Resistant Depression: Challenges and Strategies
Daphne Voineskos et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2020)
Treatment-resistant depression and peripheral C-reactive protein
Samuel R. Chamberlain et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial
Asma Kazemi et al.
CLINICAL NUTRITION (2019)
Sex differences in antidepressant efficacy
Tara A. LeGates et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Fernanda Palhano-Fontes et al.
PSYCHOLOGICAL MEDICINE (2019)
Therapeutic potential of JAK/STAT pathway modulation in mood disorders
Aisha S. Shariq et al.
REVIEWS IN THE NEUROSCIENCES (2019)
Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression
Paul Willner et al.
BEHAVIOURAL PHARMACOLOGY (2019)
Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations
Pauline M. Maki et al.
JOURNAL OF WOMENS HEALTH (2019)
Cholinergic regulation of mood: from basic and clinical studies to emerging therapeutics
Stephanie C. Dulawa et al.
MOLECULAR PSYCHIATRY (2019)
Current and Common Definitions of Treatment-Resistant Depression: Findings from a Systematic Review and Qualitative Interviews
Sage Brown et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2019)
Inflammatory profiles of severe treatment-resistant depression
Rebecca Strawbridge et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Simvastatin exerts antidepressant-like activity in mouse forced swimming test: Role of NO-cGMP-KATP channels pathway and PPAR-gamma receptors
Reza Naserzadeh et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2019)
The neuroactive potential of the human gut microbiota in quality of life and depression
Mireia Valles-Colomer et al.
NATURE MICROBIOLOGY (2019)
Sestrin modulator NV-5138 produces rapid antidepressant effects via direct mTORC1 activation
Taro Kato et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
NV-5138 as a fast-acting antidepressant via direct activation of mTORC1 signaling
Yuto Hasegawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Beyond sports: Efficacy and safety of creatine supplementation in pathological or paraphysiological conditions of brain and muscle
Maurizio Balestrino et al.
MEDICINAL RESEARCH REVIEWS (2019)
Altered Connectivity in Depression: GABA and Glutamate Neurotransmitter Deficits and Reversal by Novel Treatments
Ronald S. Duman et al.
NEURON (2019)
The critical importance of basic animal research for neuropsychiatric disorders
Tracy L. Bale et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Pharmacotherapeutic approaches to treating depression during the perimenopause
Ricardo P. Garay et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Results of the European Group for the Study of Resistant Depression (GSRD) - basis for further research and clinical practice
Lucie Bartova et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2019)
Epigenetic Regulation at the Interplay Between Gut Microbiota and Host Metabolism
Joan Miro-Blanch et al.
FRONTIERS IN GENETICS (2019)
N-Methyl-D-aspartate receptor antagonist d-methadone produces rapid, mTORC1-dependent antidepressant effects
Manoela V. Fogaca et al.
NEUROPSYCHOPHARMACOLOGY (2019)
Efficacy and tolerability of riluzole in psychiatric disorders: A systematic review and preliminary meta-analysis
J. N. de Boer et al.
PSYCHIATRY RESEARCH (2019)
Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses
Ning Yuan et al.
TRANSLATIONAL PSYCHIATRY (2019)
Creatine for the Treatment of Depression
Brent M. Kious et al.
BIOMOLECULES (2019)
Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
A. Kautzky et al.
ACTA PSYCHIATRICA SCANDINAVICA (2019)
Aberrant Epigenomic Modulation of Glucocorticoid Receptor Gene (NR3C1) in Early Life Stress and Major Depressive Disorder Correlation: Systematic Review and Quantitative Evidence Synthesis
Laurens Holmes et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial
Richard J. Zeifman et al.
FRONTIERS IN PHARMACOLOGY (2019)
A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems
Samuel T. Wilkinson et al.
DRUG DISCOVERY TODAY (2019)
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies
Sho Moriguchi et al.
MOLECULAR PSYCHIATRY (2019)
Low-dose augmentation with buprenorphine increases emotional reactivity but not reward activity in treatment resistant mid- and late-life depression
Chemin Lin et al.
NEUROIMAGE-CLINICAL (2019)
Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial
Jennifer L. Phillips et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial
Raissa Nobrega de Almeida et al.
FRONTIERS IN PSYCHOLOGY (2019)
Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies
Cheng-Ta Li et al.
FRONTIERS IN PSYCHIATRY (2019)
Adjunctive simvastatin for treatment-resistant depression: study protocol of a 12-week randomised controlled trial
Muhammad I. Husain et al.
BJPSYCH OPEN (2019)
Analysis of Clinical Trial Exit Interview Data in Patients with Treatment-Resistant Depression
Sandy Lewis et al.
PATIENT-PATIENT CENTERED OUTCOMES RESEARCH (2019)
Addressing heterogeneity (and homogeneity) in treatment mechanisms in depression and the potential to develop diagnostic and predictive biomarkers
Cynthia H. Y. Fu et al.
NEUROIMAGE-CLINICAL (2019)
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
R. L. Carhart-Harris et al.
PSYCHOPHARMACOLOGY (2018)
Epigenetic Aging in Major Depressive Disorder
Laura K. M. Han et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Injection of oxytocin into paraventricular nucleus reverses depressive-like behaviors in the postpartum depression rat model
Tong Wang et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
Emerging evidence for antidepressant actions of anesthetic agents
Scott C. Tadler et al.
CURRENT OPINION IN ANESTHESIOLOGY (2018)
Mortality in treatment-resistant unipolar depression: A register-based cohort study in Sweden
Johan Reutfors et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Tibolone improves depression in women through the menopause transition: A double-blind randomized controlled trial of adjunctive tibolone
Jayashri Kulkarni et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Exploring Nitrous Oxide as Treatment of Mood Disorders: Basic Concepts
Peter Nagele et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2018)
Treatment resistant depression: A multi-scale, systems biology approach
Huda Akil et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2018)
International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets
F. Caraci et al.
PHARMACOLOGICAL REVIEWS (2018)
Longitudinal two-photon imaging in somatosensory cortex of behaving mice reveals dendritic spine formation enhancement by subchronic administration of low-dose ketamine
Evgeny Pryazhnikov et al.
SCIENTIFIC REPORTS (2018)
Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls
Ana C. de Menezes Galvao et al.
FRONTIERS IN PSYCHIATRY (2018)
Tranylcypromine Plus Amitriptyline for Electroconvulsive Therapy-Resistant Depression: A Long-Term Study
Rafael Ferreira-Garcia et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2018)
Acetyl-L-carnitine deficiency in patients with major depressive disorder
Carla Nasca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Botulinum Toxin as a Treatment for Depression in a Real-world Setting
Sanjay Chugh et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2018)
Finding treatment-resistant depression in real-world data: How a data-driven approach compares with expert-based heuristics
M. Soledad Cepeda et al.
DEPRESSION AND ANXIETY (2018)
The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant
Joseph R. Moskal et al.
CURRENT NEUROPHARMACOLOGY (2017)
Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder
Brittany A. Jaso et al.
CURRENT NEUROPHARMACOLOGY (2017)
Evidence-based pharmacotherapy of treatment-resistant unipolar depression
Markus Dold et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2017)
Adjunctive Lanicemine (AZD6765) in Patients with Major Depressive Disorder and History of Inadequate Response to Antidepressants: A Randomized, Placebo-Controlled Study
Gerard Sanacora et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Investigational drugs in recent clinical trials for treatment-resistant depression
Ricardo P. Garay et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial
James W. Murrough et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
Population pharmacokinetic analysis of lanicemine (AZD6765), an NMDA channel blocker, in healthy subjects and patients with major depressive disorder
F. Agbo et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2017)
Case series: Antidepressant effects of low-affinity and low-trapping NMDA receptor antagonists did not predict response to ketamine in seven subjects
Lauren Lepow et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism
Lily R. Aleksandrova et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2017)
The effects of probiotics on depressive symptoms in humans: a systematic review
Caroline J. K. Wallace et al.
ANNALS OF GENERAL PSYCHIATRY (2017)
Investigational drugs in recent clinical trials for treatment-resistant depression
Ricardo P. Garay et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)
A combination of probiotics and magnesium orotate attenuate depression in a small SSRI resistant cohort: an intestinal anti-inflammatory response is suggested
Matthew Bambling et al.
INFLAMMOPHARMACOLOGY (2017)
Ketamine and Imipramine Reverse Transcriptional Signatures of Susceptibility and Induce Resilience-Specific Gene Expression Profiles
Rosemary C. Bagot et al.
BIOLOGICAL PSYCHIATRY (2017)
The chronic mild stress (CMS) model of depression: History, evaluation and usage
Paul Willner
NEUROBIOLOGY OF STRESS (2017)
Chronic psychosocial stressors in adulthood: Studies in mice, rats and tree shrews
Christopher R. Pryce et al.
NEUROBIOLOGY OF STRESS (2017)
D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review
Sebastian Schade et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research
Michael Maes et al.
MOLECULAR NEUROBIOLOGY (2016)
Valproate augmentation in a subgroup of patients with treatment-resistant unipolar depression
Maykel F. Ghabrash et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2016)
Ketamine: 50 Years of Modulating the Mind
Linda Li et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2016)
Continuation phase intravenous ketamine in adults with treatment resistant depression
Jennifer L. Vande Voort et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Evidence to Support Montgomery-Asberg Depression Rating Scale Administration Every 24 Hours to Assess Rapid Onset of Treatment Response
Kristen M. Johnson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression A SPECT Study
Rafael Faria Sanches et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2016)
Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat
John R. Kelly et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
The potential use of histone deacetylase inhibitors in the treatment of depression
Manabu Fuchikami et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Animal models of major depression and their clinical implications
Boldizar Czeh et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression A Randomized Clinical Trial
Jorge A. Quiroz et al.
JAMA PSYCHIATRY (2016)
Childhood trauma predicts antidepressant response in adults with major depression: data from the randomized international study to predict optimized treatment for depression
L. M. Williams et al.
TRANSLATIONAL PSYCHIATRY (2016)
Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response
Q. S. Li et al.
TRANSLATIONAL PSYCHIATRY (2016)
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
Robin L. Carhart-Harris et al.
LANCET PSYCHIATRY (2016)
Rodent models of treatment-resistant depression
Barbara J. Caldarone et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Assessment of the Efficacy and Safety of BMS-820836 in Patients With Treatment-Resistant Major Depression Results From 2 Randomized, Double-Blind Studies
Zubin Bhagwagar et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2015)
Determinants of Treatment-Resistant Depression The Salience of Benzodiazepines
Gordon B. Parker et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2015)
Randomized Proof of Concept Trial of GLYX-13, an N-Methyl-D-Aspartate Receptor Glycine Site Partial Agonist, in Major Depressive Disorder Nonresponsive to a Previous Antidepressant Agent
Sheldon Preskorn et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2015)
Spine synapse remodeling in the pathophysiology and treatment of depression
Catharine H. Duman et al.
NEUROSCIENCE LETTERS (2015)
Treatment-resistant depression: are animal models of depression fit for purpose?
Paul Willner et al.
PSYCHOPHARMACOLOGY (2015)
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Flavia de L. Osorio et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2015)
Depression - An emerging indication for botulinum toxin treatment
Tillmann H. C. Kruger et al.
TOXICON (2015)
Circadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder
B. G. Bunney et al.
MOLECULAR PSYCHIATRY (2015)
Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study
Tracy L. Hellem et al.
JOURNAL OF DUAL DIAGNOSIS (2015)
Pharmacologic approaches to treatment resistant depression: Evidences and personal experience
Antonio Tundo et al.
WORLD JOURNAL OF PSYCHIATRY (2015)
Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression
Lothar Lindemann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Enduring Deficits in Brain Reward Function after Chronic Social Defeat in Rats: Susceptibility, Resilience, and Antidepressant Response
Andre Der-Avakian et al.
BIOLOGICAL PSYCHIATRY (2014)
The impact of childhood adversity on suicidality and clinical course in treatment-resistant depression
Catherine Tunnard et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Safety, Tolerability, and Clinical Effect of Low-Dose Buprenorphine for Treatment-Resistant Depression in Midlife and Older Adults
Jordan F. Karp et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects
G. Sanacora et al.
MOLECULAR PSYCHIATRY (2014)
Making room for oxytocin in understanding depression
Robyn J. McQuaid et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Depression in the Elderly
Warren D. Taylor
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ketamine - More mechanisms of action than just NMDA blockade
Jamie Sleigh et al.
TRENDS IN ANAESTHESIA AND CRITICAL CARE (2014)
New paradigms for treatment-resistant depression
Carlos Zarate et al.
ANNALS REPORTS (2013)
Chronic adrenocorticotrophic hormone treatment alters tricyclic antidepressant efficacy and prefrontal monoamine tissue levels
Adam J. Walker et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2013)
Towards translational rodent models of depression
Olivia F. O'Leary et al.
CELL AND TISSUE RESEARCH (2013)
Epigenetics of the Depressed Brain: Role of Histone Acetylation and Methylation
HaoSheng Sun et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Potential therapeutic uses of mecamylamine and its stereoisomers
Justin R. Nickell et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
Charles L. Raison et al.
JAMA PSYCHIATRY (2013)
Treatment-resistant and insufficiently treated depression and all-cause mortality following myocardial infarction
Jeffrey F. Scherrer et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
Intrahippocampal transplantation of mesenchymal stromal cells promotes neuroplasticity
Nicolas Coquery et al.
CYTOTHERAPY (2012)
Phosphorylation of MeCP2 at Ser421 Contributes to Chronic Antidepressant Action
Ashley N. Hutchinson et al.
JOURNAL OF NEUROSCIENCE (2012)
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010
Christopher J. L. Murray et al.
LANCET (2012)
Are We Getting Closer to Valid Translational Models for Major Depression?
Olivier Berton et al.
SCIENCE (2012)
Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes
S. J. Sukoff Rizzo et al.
TRANSLATIONAL PSYCHIATRY (2012)
Cross-national epidemiology of DSM-IV major depressive episode
Evelyn Bromet et al.
BMC MEDICINE (2011)
BIOMARKERS OF ANHEDONIC-LIKE BEHAVIOR, ANTIDEPRESSANT DRUG REFRACTION, AND STRESS RESILIENCE IN A RAT MODEL OF DEPRESSION
T. Christensen et al.
NEUROSCIENCE (2011)
Therapeutic Options for Treatment-Resistant Depression
Richard C. Shelton et al.
CNS DRUGS (2010)
Animal models of neuropsychiatric disorders
Eric J. Nestler et al.
NATURE NEUROSCIENCE (2010)
Association between Repeated Unpredictable Chronic Mild Stress (UCMS) Procedures with a High Fat Diet: A Model of Fluoxetine Resistance in Mice
Elsa Isingrini et al.
PLOS ONE (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Treatment-Resistant Depression and Mortality After Acute Coronary Syndrome
Robert M. Carney et al.
AMERICAN JOURNAL OF PSYCHIATRY (2009)
Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression
Anteneh M. Feyissa et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Does minocycline have antidepressant effect?
Chi-Un Pae et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study
Daniel Souery et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Dopamine D2-like receptors and the antidepressant response
Ari A. Gershon et al.
BIOLOGICAL PSYCHIATRY (2007)
Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression
Magdalena N. Jayatissa et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Treatment of depression with botulinum toxin A: A case series
Eric Finzi et al.
DERMATOLOGIC SURGERY (2006)
Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression
PV Choudary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Pharmacokinetics of dextromethorphan after single or multiple dosing in combination with quinidine in extensive and poor metabolizers
LE Pope et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Diagnosis and definition of treatment-resistant depression
M Fava
BIOLOGICAL PSYCHIATRY (2003)
Influence of ACTH on the effects of imipramine, desipramine and lithium on duration of immobility of rats in the forced swim test
Y Kitamura et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2002)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
分享论文
